<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vsp</journal-id><journal-title-group><journal-title xml:lang="ru">Вопросы современной педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Current Pediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-5527</issn><issn pub-type="epub">1682-5535</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/vsp.v12i4.731</article-id><article-id custom-type="elpub" pub-id-type="custom">vsp-305</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>МОЛЕКУЛЫ АДГЕЗИИ ПРИ ДЕСТРУКТИВНО-ВОСПАЛИТЕЛЬНОМ ПРОЦЕССЕ В КИШЕЧНИКЕ У ДЕТЕЙ С ЯЗВЕННЫМ КОЛИТОМ</article-title><trans-title-group xml:lang="en"><trans-title>ADHESION MOLECULES IN INTESTINAL DESTRUCTIVE-INFLAMMATORY PROCESS IN THE CHILDREN WITH ULCERATIVE COLITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ашкинази</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ashkinazi</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="en"><p>Ashkinazi Vladimir Izrail’evich, MD, senior research assistant of Laboratory of Clinical Immunology</p></bio><email xlink:type="simple">vladash58@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маянская</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mayanskaya</surname><given-names>I. V.</given-names></name></name-alternatives><email xlink:type="simple">vladash58@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Толкачёва</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tolkacheva</surname><given-names>N. I.</given-names></name></name-alternatives><email xlink:type="simple">vladash58@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федулова</surname><given-names>Э. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedulova</surname><given-names>E. N.</given-names></name></name-alternatives><email xlink:type="simple">vladash58@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Широкова</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shirokova</surname><given-names>N. Yu.</given-names></name></name-alternatives><email xlink:type="simple">vladash58@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasil'eva</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">vladash58@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шумилова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shumilova</surname><given-names>O.V.</given-names></name></name-alternatives><email xlink:type="simple">vladash58@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Нижегородский НИИ детской гастроэнтерологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nizhny Novgorod Research Institute of Children Gastroenterology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>12</day><month>07</month><year>2013</year></pub-date><volume>12</volume><issue>4</issue><issue-title>Вопросы современной педиатрии</issue-title><fpage>52</fpage><lpage>56</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ашкинази В.И., Маянская И.В., Толкачёва Н.И., Федулова Э.Н., Широкова Н.Ю., Васильева Е.А., Шумилова О.В., 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Ашкинази В.И., Маянская И.В., Толкачёва Н.И., Федулова Э.Н., Широкова Н.Ю., Васильева Е.А., Шумилова О.В.</copyright-holder><copyright-holder xml:lang="en">Ashkinazi V.I., Mayanskaya I.V., Tolkacheva N.I., Fedulova E.N., Shirokova N.Y., Vasil'eva E.A., Shumilova O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vsp.spr-journal.ru/jour/article/view/305">https://vsp.spr-journal.ru/jour/article/view/305</self-uri><abstract><p>Цель исследования: изучить в сыворотке крови детей с язвенным колитом содержание растворимых форм молекул клеточной адгезии, опосредующих начальный и заключительный этап миграции лейкоцитов в очаг воспаления — sP-селектина (soluble platelet selectin) и sPECAM-1 (soluble platelet-endothelial cell adhesion molecule 1), а также некоторых ранее не исследованных факторов, взаимосвязанных с их уровнем. Пациенты и методы: обследовано 107 пациентов в возрасте от 6 до 17 лет, страдающих язвенным колитом. Диагноз ставили на основании комплексного обследования. Определение содержания растворимых молекул адгезии sP-селектина и sPECAM-1 в сыворотке крови, а также цитокиновый статус оценивали при помощи иммуноферментного анализа. Респираторный метаболизм изучали с использованием хемилюминесцентных реакций. Результаты: установлено, что содержание sP-селектина и sPECAM-1 у больных значимо выше, чем в контрольной группе, что может оказывать влияние на процесс миграции лейкоцитов в ткани для реализации своего эффекторного потенциала. Это подтверждается морфологическими исследованиями биоптатов кишечника: наблюдали увеличение числа лейкоцитов в эндотелии сосудов и эпителиальном пласте. Одновременно отмечено усиление кислородзависимого метаболизма нейтрофилов, увеличение концентрации неоптерина и фактора некроза опухоли α. Выводы: обнаружена взаимосвязь изученных адгезивных молекул с рядом маркеров воспаления, таких как фактор некроза опухоли α, свободные радикалы, неоптерин, что свидетельствует о диагностической значимости сывороточного уровня мембранных антигенов. Увеличение концентрации адгезивных молекул sP-селектина и sPECAM-1 может быть одним из звеньев патогенеза язвенного колита.</p></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim: to study the content of serum soluble cell adhesion molecules in children with ulcerative colitis that mediate the initial and final stages of the migration of leukocytes to the focus of inflammation: sP-selectin (soluble platelet selectin) and Specam-1 (soluble platelet-endothelial cell adhesion molecule 1) as well some earlier unexplored factors associated with their level. Patients and methods: we examined 107 patients with ulcerative colitis aged from 6 up to 17 years. The diagnosis was set on the base of a comprehensive examination. The content of serum soluble adhesion molecules sP-selectin and sPECAM-1 as well cytokine status and neopterin were evaluated by ELISA. Respiratory metabolism was investigated by using chemiluminescent reactions. Results: it was shown that the content of sP-selectin and sPECAM-1 is significantly higher in patients than in the control group, which may influence on the migration of leukocytes into tissues for realization of their effector potential. It is confirmed by morphological analyses of the intestine biopsies, where it was observed the increasing of the number of leukocytes in vascular endothelium and epithelial layer. At the same time strengthening of the oxygen-dependent metabolism of neutrophils, the increase of the concentration of neopterin and tumor necrosis factor α were noted. Conclusions: the correlation of the studied adhesion molecules with a number of inflammatory markers (TNFα (tumor necrosis factor α), free radicals, neopterin) was revealed, which indicates the diagnostic value of serum levels of the membrane antigens. The increase of the concentration of adhesion molecules sP-selectin and sPECAM-1 may be one of the links of the pathogenesis of ulcerative colitis.</p></sec><sec><title> </title><p> </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>язвенный колит</kwd><kwd>растворимые молекулы адгезии</kwd><kwd>маркеры воспаления</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ulcerative colitis</kwd><kwd>soluble adhesion molecules</kwd><kwd>markers of inflammation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Baranov A. A., Potapov A. S., Tsimbalova E. G. Vestnik Rossiiskoi akademii meditsinskikh nauk — Annals of the Russian Academy of Medical Sciences. 2011; 6: 36–41.</mixed-citation><mixed-citation xml:lang="en">Baranov A. A., Potapov A. S., Tsimbalova E. G. Vestnik Rossiiskoi akademii meditsinskikh nauk — Annals of the Russian Academy of Medical Sciences. 2011; 6: 36–41.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Khalif I. L., Mikhailova T. L., Belousova E. A. Konservativnoe lechenie yazvennogo kolita i bolezni Krona. V kn.: Nespetsificheskie zabole vaniya kishechnika. Pod red. G. I. Vorob'eva, I. L. Khalifa [Medical Treatment of Ulcerative Colitis and Chronic Cicatrizing Enteritis. In book: Heterospecific Enteropathy]. Moscow, Miklosh, 2008. pp. 247–250.</mixed-citation><mixed-citation xml:lang="en">Khalif I. L., Mikhailova T. L., Belousova E. A. Konservativnoe lechenie yazvennogo kolita i bolezni Krona. V kn.: Nespetsificheskie zabole vaniya kishechnika. Pod red. G. I. Vorob'eva, I. L. Khalifa [Medical Treatment of Ulcerative Colitis and Chronic Cicatrizing Enteritis. In book: Heterospecific Enteropathy]. Moscow, Miklosh, 2008. pp. 247–250.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Papadakis K.A., Targan S. R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Ann. Rev. Med. 2000; 51: 289–298.</mixed-citation><mixed-citation xml:lang="en">Papadakis K.A., Targan S. R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Ann. Rev. Med. 2000; 51: 289–298.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">van Assche G., Rutgeerts P. Antiandhesion molecule therapy in inflammatory bowel disease. Inflamm. Bowel Dis. 2002; 8: 291–300.</mixed-citation><mixed-citation xml:lang="en">van Assche G., Rutgeerts P. Antiandhesion molecule therapy in inflammatory bowel disease. Inflamm. Bowel Dis. 2002; 8: 291–300.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mac Donald T. T., Monteleone G. Adaptive immunity: Effector and inhibitory cytokine pathways in gut inflammation. In: S. R. Targan, F. Shanahan, L. C. Karp (eds.). Inflammatory bowel disease. Translating basic science into clinical practice. Chichester: WileyBlackwell. 2010. P. 82–91.</mixed-citation><mixed-citation xml:lang="en">Mac Donald T. T., Monteleone G. Adaptive immunity: Effector and inhibitory cytokine pathways in gut inflammation. In: S. R. Targan, F. Shanahan, L. C. Karp (eds.). Inflammatory bowel disease. Translating basic science into clinical practice. Chichester: WileyBlackwell. 2010. P. 82–91.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Novikov V. V., Karaulov A. V., Baryshnikov A.Yu. Immunologiya — Immunology. 2007; 4: 249–253.</mixed-citation><mixed-citation xml:lang="en">Novikov V. V., Karaulov A. V., Baryshnikov A.Yu. Immunologiya — Immunology. 2007; 4: 249–253.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Pinegin B. V., Mayanskii A. N. Immunologiya — Immunology. 2007; 6: 374–382.</mixed-citation><mixed-citation xml:lang="en">Pinegin B. V., Mayanskii A. N. Immunologiya — Immunology. 2007; 6: 374–382.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mayanskii D. N. Lektsii po klinicheskoi patologii [Lectures on Clinical Pathology]. Moscow, GEOTAR-Media, 2008. pp. 15–78.</mixed-citation><mixed-citation xml:lang="en">Mayanskii D. N. Lektsii po klinicheskoi patologii [Lectures on Clinical Pathology]. Moscow, GEOTAR-Media, 2008. pp. 15–78.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Song W. B., Lv Yn., Zhang Z. S., Li Yn., Xiao L. P., Yu X. P., Wang Y. Y., Ji H. L., Ma L. Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease. World J. Gastroenterol. 2009; 15 (31): 3916–3919.</mixed-citation><mixed-citation xml:lang="en">Song W. B., Lv Yn., Zhang Z. S., Li Yn., Xiao L. P., Yu X. P., Wang Y. Y., Ji H. L., Ma L. Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease. World J. Gastroenterol. 2009; 15 (31): 3916–3919.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Goggins M. G., O, Connell M. A., Weir D. G., Kelleher D., Mahmud N. Soluble adhesion molecules in inflammatory bowel disease. Irish. J. Med. Sci. 2001; 170 (2): 107–111.</mixed-citation><mixed-citation xml:lang="en">Goggins M. G., O, Connell M. A., Weir D. G., Kelleher D., Mahmud N. Soluble adhesion molecules in inflammatory bowel disease. Irish. J. Med. Sci. 2001; 170 (2): 107–111.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pavlenko V. V., Amirkhanova L. Z. Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii — The Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2009; 5: 61.</mixed-citation><mixed-citation xml:lang="en">Pavlenko V. V., Amirkhanova L. Z. Rossiiskii zhurnal gastroenterologii gepatologii koloproktologii — The Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2009; 5: 61.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Polinska B., Matowiska-Karna J., Kemona H. Assessment of the influence of the inflammatory process on the activation of blood platelets and morphological parameters in patients with ulcerative colitis (colitis ulcerosa). Folia Histochem. Cytobiol. 2011; 1: 119–124.</mixed-citation><mixed-citation xml:lang="en">Polinska B., Matowiska-Karna J., Kemona H. Assessment of the influence of the inflammatory process on the activation of blood platelets and morphological parameters in patients with ulcerative colitis (colitis ulcerosa). Folia Histochem. Cytobiol. 2011; 1: 119–124.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dymiska-Piekarska V., Kemona H. Does colorectal cancer clinical advancement affect adhesion molecules (sP-selectin, sЕ — selectin and sICAM- 1) concentration? Thromb. Res. 2009; 1: 80–83.</mixed-citation><mixed-citation xml:lang="en">Dymiska-Piekarska V., Kemona H. Does colorectal cancer clinical advancement affect adhesion molecules (sP-selectin, sЕ — selectin and sICAM- 1) concentration? Thromb. Res. 2009; 1: 80–83.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Magro F., Araujo F., Pereira P., Meireles E., Diniz-Ribeiro M., Velosom F. T. Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease. Dig. Dis. Sci. 2004; 49 (7–8): 1265–1274.</mixed-citation><mixed-citation xml:lang="en">Magro F., Araujo F., Pereira P., Meireles E., Diniz-Ribeiro M., Velosom F. T. Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease. Dig. Dis. Sci. 2004; 49 (7–8): 1265–1274.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Adamska I., Czerwionka-Szaflarska M., Kulwas A., Mierzwa G., Bala G., Rosc D. Value of E-selectin and L-selectin determination in children and youth with inflammatory bowel disease. Med. Wieku. Rozwoj. 2007; 11 (4): 413–418.</mixed-citation><mixed-citation xml:lang="en">Adamska I., Czerwionka-Szaflarska M., Kulwas A., Mierzwa G., Bala G., Rosc D. Value of E-selectin and L-selectin determination in children and youth with inflammatory bowel disease. Med. Wieku. Rozwoj. 2007; 11 (4): 413–418.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Adamska I., Czerwionka-Szaflarska M., Kulwas A., Mierzwa G., Bala G., Rosc D. Adhesion molecules of immunoglobin super family in children and youth with inflammatory bowel disease. Pol. Merkur. Lecarski. 2009; 26 (152): 101–104.</mixed-citation><mixed-citation xml:lang="en">Adamska I., Czerwionka-Szaflarska M., Kulwas A., Mierzwa G., Bala G., Rosc D. Adhesion molecules of immunoglobin super family in children and youth with inflammatory bowel disease. Pol. Merkur. Lecarski. 2009; 26 (152): 101–104.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mayanskaya I. V., Shabunina E. I., Ashkinazi V. I., Tolkacheva N. I., Potekhin P. P. Voprosi diagnostiki v pediatrii — Diagnostics in pediatrics. 2009; 1: 28–32.</mixed-citation><mixed-citation xml:lang="en">Mayanskaya I. V., Shabunina E. I., Ashkinazi V. I., Tolkacheva N. I., Potekhin P. P. Voprosi diagnostiki v pediatrii — Diagnostics in pediatrics. 2009; 1: 28–32.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
